Search results
Donanemab for Alzheimer's Gets Thumbs Up From FDA Panel
Medscape· 4 days agoAn 11-member advisory panel to the US Food and Drug Administration (FDA) has unanimously concluded...
Once-Weekly Somapacitan Remains Safe, Effective Long-Term
Medscape· 7 days agoGrowth improvements were similar between children taking somapacitan for 3 years and those who...
EULAR 2024 Preview: What's Not to Miss?
Medscape· 4 days agoEULAR 2024 Preview: What's Not to Miss at This Year's Congress? The European Alliance of Associations for Rheumatology (EULAR) 2024 European Congress of...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 3 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, in an advanced clinical trial that included ...
Stock Split Watch: 3 Growth Stocks That Could Be Next | The Motley Fool
The Motley Fool· 6 days agoAmong them are MercadoLibre (MELI -1.29%), Booking Holdings (BKNG 0.31%), and Regeneron (REGN...
The ultimate guide to travel vaccinations
The Telegraph via Yahoo News· 3 days agoWherever your travels take you, whatever the purpose of your trip, finding out about likely health risks at your destination – and how to reduce them –...
3 No-Brainer Nasdaq Stocks to Buy in June
247wallst.com· 3 days agoInvestors looking for a ton of value and a place to put some of the gains from the huge technology move should consider these top stocks.
First Generation to Have More Cancer Than Their Parents
Medscape· 3 days agoBut how worried should we be? Dr F Perry Wilson breaks it all down.
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 3 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment ...
NC bill advances to force Chemours, others to pay for harm done to drinking water by PFAS
The News & Observer· 1 day agoA renewed legislative effort to force Chemours and other forever chemical manufacturers to pay for...
